Ma, Lijiang
Bayram, Yavuz
McLaughlin, Heather M.
Cho, Megan T.
Krokosky, Alyson
Turner, Clesson E.
Lindstrom, Kristin
Bupp, Caleb P.
Mayberry, Katey
Mu, Weiyi
Bodurtha, Joann
Weinstein, Veronique
Zadeh, Neda
Alcaraz, Wendy
Powis, Zöe
Shao, Yunru
Scott, Daryl A.
Lewis, Andrea M.
White, Janson J.
Jhangiani, Shalani N.
Gulec, Elif Yilmaz
Lalani, Seema R.
Lupski, James R.
Retterer, Kyle
Schnur, Rhonda E.
Wentzensen, Ingrid M.
Bale, Sherri
Chung, Wendy K.
Funding for this research was provided by:
Simons Foundation
National Institutes of Health (GM030518)
National Institute of Neurological Disorders and Stroke (NS058529)
National Human Genome Research Institute (HG006542)
Article History
Received: 29 July 2016
Accepted: 19 September 2016
First Online: 28 September 2016
Compliance with ethical standards
:
: Heather McLaughlin, Megan Cho, Kyle Retterer, Rhonda Schnur, Ingrid Wentzensen, and Sherri Bale are employees of GeneDx. Wendy Chung is a former employee of GeneDx and a paid consultant for Regeneron Pharmaceuticals. JRL has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., serves on the Scientific Advisory Board of the Baylor Miraca Genetics Laboratory, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The other authors declare that they have no conflict of interest.